- 3M is putting a price on its biggest remaining PFAS risk. The company committed $7.35 billion over nine years to settle litigation tied to the chemicals known as PFAS, covering almost all of the 115,000 to 120,000 personal injury claims being litigated in and outside a federal court in South Carolina. Shares rose 1.7% in late trading in New York.
- The payments are heavily back-loaded. 3M will pay $50 million in 2026 and nothing in 2027, with about 20% of payments due in the final two years, about $1.47 billion by our calculation. The company said the schedule will “align to 3M’s remaining payment obligations for other legacy settlements.”
- It adds to an already large bill. In 2023, 3M agreed to pay as much as $12.5 billion over 13 years to US public water suppliers, and last year it settled New Jersey PFAS claims with a pre-tax charge of about $285 million. Together with the new deal, the water and injury settlements total about $19.85 billion by our calculation.
- The overhang is shrinking but not gone. Before this deal, Bloomberg Intelligence estimated 3M’s legal overhang could reach $20 billion. BI estimates that remaining claims tied to contamination of water sources could still cost as much as $15 billion to settle.
What Happened?
3M said on Tuesday that the settlement will address nearly all personal injury claims tied to its history of making per- and polyfluoroalkyl substances, which were used in products such as stain-proof textiles and firefighting foams at military bases and airports. The EPA has concluded that PFAS, which do not break down naturally and persist in drinking water and soil, are linked to higher cancer risks. Plaintiffs have blamed the chemicals for illnesses including kidney and testicular cancer, thyroid disease and ulcerative colitis, and payouts will vary by plaintiff. Chief Executive William Brown said the deal “substantially reduces litigation uncertainty.”
Why It Matters?
For shareholders, the structure matters as much as the headline number. With $50 million this year and no payments in 2027, almost all of the cash burden falls in 2028 and later, which protects near-term free cash flow. 3M fully exited PFAS manufacturing at the end of 2025, so the remaining risk is legacy liability rather than ongoing business exposure. The stock had gained 11% this year through Tuesday’s close, in line with the S&P 500, suggesting investors had already priced in a large settlement.
What’s Next?
The next step is getting the deal finalized and confirming how many claimants accept it. Investors will also watch for any accounting charge tied to the commitment and for progress on the remaining water contamination claims, which Bloomberg Intelligence puts at up to $15 billion. If those are resolved too, 3M could largely put its PFAS legacy behind it.
Affected Tickers and Coins: MMM
Source: Bloomberg
